Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582–98.
CAS PubMed Article Google Scholar
Liu T, Han C, Wang S, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12(1):86.
CAS PubMed PubMed Central Article Google Scholar
Kanzaki R, Pietras K. Heterogeneity of cancer-associated fibroblasts: opportunities for precision medicine. Cancer Sci. 2020;111(8):2708–17.
CAS PubMed PubMed Central Article Google Scholar
Shi Y, Du L, Lin L, Wang Y. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov. 2017;16(1):35–52.
CAS PubMed Article Google Scholar
Liang W, Chen X, Zhang S, et al. Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines. Cell Mol Biol Lett. 2021;26(1):1–25.
Costa A, Kieffer Y, Scholer-Dahirel A, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33(3):463-79 e10.
CAS PubMed Article Google Scholar
Pelon F, Bourachot B, Kieffer Y, et al. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nat Commun. 2020;11(1):404.
CAS PubMed PubMed Central Article Google Scholar
Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–22.
CAS PubMed Article Google Scholar
Bhagat TD, Von Ahrens D, Dawlaty M, et al. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. 2019. https://doi.org/10.7554/eLife.50663.
Article PubMed PubMed Central Google Scholar
Galluzzi L, Kroemer G. Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate. Oncoimmunology. 2018;7(12): e1528815.
PubMed PubMed Central Article Google Scholar
Dvořák A, Zelenka J, Smolková K, Vítek L, JeŽek P. Background levels of neomorphic 2-hydroxyglutarate facilitate proliferation of primary fibroblasts. Physiol Res. 2017;66(2):293–304.
Younesi FS, Son DO, Firmino J, Hinz B. Myofibroblast markers and microscopy detection methods in cell culture cell cultures and histology. In: Hinz B, Lagares D, editors. Myofibroblasts: methods and protocols. New York: Springer; 2021. p. 17–47.
Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436–50.
CAS PubMed PubMed Central Article Google Scholar
Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473. https://doi.org/10.1126/science.aaw5473.
Ursini-Siegel J, Siegel PM. The influence of the pre-metastatic niche on breast cancer metastasis. Cancer Lett. 2016;380(1):281–8.
CAS PubMed Article Google Scholar
Mittal S, Brown NJ, Holen I. The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Rev Mol Diagn. 2018;18(3):227–43.
CAS PubMed Article Google Scholar
Qian J, Olbrecht S, Boeckx B, et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 2020;30(9):745–62.
CAS PubMed PubMed Central Article Google Scholar
Hass R, von der Ohe J, Ungefroren H. Impact of the tumor microenvironment on tumor heterogeneity and consequences for cancer cell plasticity and stemness. Cancers (Basel). 2020;12(12):3716. https://doi.org/10.3390/cancers12123716
Wegiel B, Vuerich M, Daneshmandi S, Seth P. Metabolic switch in the tumor microenvironment determines immune responses to anti-cancer therapy. Front Oncol. 2018;8:284.
PubMed PubMed Central Article Google Scholar
Wang JX, Choi SYC, Niu X, et al. Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21218363.
Article PubMed PubMed Central Google Scholar
Erra Díaz F, Dantas E, Geffner J. Unravelling the Interplay between extracellular acidosis and immune cells. Mediators Inflamm. 2018;2018:1218297.
PubMed PubMed Central Article CAS Google Scholar
Certo M, Tsai C-H, Pucino V, Ho P-C, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21(3):151–61.
CAS PubMed Article Google Scholar
Terrén I, Orrantia A, Vitallé J, Zenarruzabeitia O, Borrego F. NK cell metabolism and tumor microenvironment. Front Immunol. 2019;10:2278. https://doi.org/10.3389/fimmu.2019.02278.
Long Y, Gao Z, Hu X, et al. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma. Cancer Med. 2018;7(9):4690–700.
CAS PubMed PubMed Central Article Google Scholar
Chang CH, Qiu J, O’Sullivan D, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell. 2015;162(6):1229–41.
CAS PubMed PubMed Central Article Google Scholar
Xia L, Oyang L, Lin J, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28.
PubMed PubMed Central Article Google Scholar
Liang W, Chen X, Zhang S, et al. Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines. Cell Mol Biol Lett. 2021;26(1):3.
CAS PubMed PubMed Central Article Google Scholar
Hilmi M, Nicolle R, Bousquet C, Neuzillet C. Cancer-associated fibroblasts: accomplices in the tumor immune evasion. Cancers. 2020;12(10):2969.
CAS PubMed Central Article Google Scholar
Chung B, Esmaeili AA, Gopalakrishna-Pillai S, et al. Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. NPJ Breast Cancer. 2017;3:6.
PubMed PubMed Central Article CAS Google Scholar
Fricker SP, Anastassov V, Cox J, et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol. 2006;72(5):588–96.
CAS PubMed Article Google Scholar
Feig C, Jones JO, Kraman M, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci USA. 2013;110(50):20212–7.
CAS PubMed PubMed Central Article Google Scholar
Zou F, Zhang ZH, Zhang YT, et al. Cancer-associated-fibroblasts regulate the chemoresistance of lung cancer cell line A549 via SDF-1 secretion. Zhonghua zhong liu za zhi [Chin J Oncol]. 2017;39(5):339–43.
Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth–bystanders turning into key players. Curr Opin Genet Dev. 2009;19(1):67–73.
PubMed Article CAS Google Scholar
Fu C, Jiang A. Dendritic cells and CD8 T cell immunity in tumor microenvironment. Front Immunol. 2018;9:3059. https://doi.org/10.3389/fimmu.2018.03059
Calon A, Tauriello DV, Batlle E. TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol. 2014;25:15–22.
CAS PubMed Article Google Scholar
Kouidhi S, Elgaaied AB, Chouaib S. Impact of metabolism on T-cell differentiation and function and cross talk with tumor microenvironment. Front Immunol. 2017;8:270.
PubMed PubMed Central Article CAS Google Scholar
Kurelac I, Ganesh NU, Iorio M, Porcelli AM, Gasparre G. The multifaceted effects of metformin on tumor microenvironment. Semin Cell Dev Biol. 2020;98:90–97. https://doi.org/10.1016/j.semcdb.2019.05.010.
Shao S, Zhao L, An G, et al. Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer. FASEB J. 2020;34(8):10860–70.
CAS PubMed Article Google Scholar
Wu Z, Zhang C, Najafi M. Targeting of the tumor immune microenvironment by metformin. J Cell Commun Signal. 2021. https://doi.org/10.1007/s12079-021-00648-w.
Pértega-Gomes N, Vizcaíno JR, Attig J, Jurmeister S, Lopes C, Baltazar F. A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer. BMC Cancer. 2014;14:352.
PubMed PubMed Central Article CAS Google Scholar
Lyssiotis CA, Kimmelman AC. Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 2017;27(11):863–75.
CAS PubMed PubMed Central Article Google Scholar
Fadaka A, Ajiboye B, Ojo O, Adewale O, Olayide I, Emuowhochere R. Biology of glucose metabolization in cancer cells. J Oncol Sci. 2017;3(2):45–51.
Annibaldi A, Widmann C. Glucose metabolism in cancer cells. Curr Opin Clin Nutr Metab Care. 2010;13(4):466–70.
留言 (0)